Dihydropyridine calcium channel blockers and obstructive sleep apnea: Two underrecognized causes of nocturia?

Santiapillai, Joseph; Tadtayev, Sergey; Miles, Alenka; Arumainayagam, Nimalan; Yeong, Keefai; Murray, Paul

Santiapillai, Joseph; Tadtayev, Sergey; Miles, Alenka; Arumainayagam, Nimalan; Yeong, Keefai; Murray, Paul.

Afiliação

Santiapillai J; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
Tadtayev S; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
Miles A; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
Arumainayagam N; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
Yeong K; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.
Murray P; Ashford and St. Peter's Hospitals NHS Foundation Trust, Chertsey, UK.

Neurourol Urodyn ; 39(5): 1612-1614, 2020 06.

Article em En | MEDLINE | ID: mdl-32315095

Assuntos

Di-Hidropiridinas; Noctúria; Apneia Obstrutiva do Sono; Bloqueadores dos Canais de Cálcio; Humanos; Encaminhamento e Consulta

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidropiridinas / Apneia Obstrutiva do Sono / Noctúria Tipo de estudo: Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google